companydata.dkNBCD A/S: Financial statements 2016
CVR: 30582462
NBCD A/S (CVR 30582462) has filed annual accounts for 2016. In 2016, the company reported a gross profit of DKK 12,735,938 and a net result of DKK 13,977,615 compared with DKK 37,890,921 the year before. Equity amounted to DKK 9,715,059. The solvency ratio was 33.8%.
- Gross Profit
- 12,735,938 kr.
- Profit/Loss
- 13,977,615 kr.
- Equity
- 9,715,059 kr.
- Total Assets
- 28,753,260 kr.
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2016 | - | 12.7 mio. | 14 mio. | 9.7 mio. | - |
| 2015 | - | -6.1 mio. | 37.9 mio. | 44.2 mio. | - |
| 2014 | - | 1.6 mio. | 29.2 mio. | 6.3 mio. | - |
| 2013 | - | -3.4 mio. | -11.8 mio. | -22.9 mio. | - |
| 2012 | - | - | - | 500 t. | - |
How creditworthy is NBCD A/S?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2016
NBCD A/S has published its annual report for 2015. Gross profit came to DKK -6,080,089, and the net result was DKK 37,890,921.
About NBCD A/S
NBCD A/S is a Danish company of the type Aktieselskab based in Søborg, founded in 2007. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named NORDIC BIOSCIENCE CLINICAL DEVELOPMENT A/S and NORDIC BIOSCIENCE PROJECT 2 A/S. The management consists of Jeppe Ragnar Andersen and Mark Høgh Gandrup. The company is owned by Sanos Holding A/S. The company has 24 employees. In 2025, the company reported a gross profit of DKK 31,583,144 and a net result of DKK 9,222,892 compared with DKK 52,621,101 the year before. Equity amounted to DKK 136,144,994.